Maternal nicotine exposure during gestation and lactation induces cardiac remodeling in rat offspring

Reproductive Toxicology

Volumn 50, Issue , 2014, Pages 4-10

  Chou, Hsiu Chu ^a   Chen, Chung Ming ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Collagen; Myosin heavy chain; Nicotine; Transforming growth factor 1

Indexed keywords

COLLAGEN; MYOSIN HEAVY CHAIN BETA; NICOTINE; TRANSFORMING GROWTH FACTOR BETA1; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC REMODELING; CELL COUNT; CELL SIZE; COLLAGEN METABOLISM; CONTROLLED STUDY; DISEASE ACTIVITY; ENVIRONMENTAL EXPOSURE; FEMALE; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; LACTATION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PREGNANCY; PRENATAL CARE; PRENATAL EXPOSURE; PROGENY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ANIMAL; BODY WEIGHT; DRUG EFFECTS; FETUS HEART; METABOLISM; ORGAN SIZE; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; COLLAGEN; FEMALE; FETAL HEART; LACTATION; MATERNAL EXPOSURE; MYOSIN HEAVY CHAINS; NICOTINE; ORGAN SIZE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84908319476     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2014.09.013     Document Type: Article

References (45)

1. Oberg M., Jaakkola M.S., Woodward A., Peruga A., Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 2011, 377:139-146.
2. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
3. Abbott L.C., Winzer-Serhan U.H. Smoking during pregnancy: lessons learned from epidemiological studies and experimental studies using animal models. Crit Rev Toxicol 2012, 42:279-303.
4. Tsui H.C., Wu H.D., Lin C.J., Wang R.Y., Chiu H.T., Cheng Y.C., et al. Prenatal smoking exposure and neonatal DNA damage in relation to birth outcomes. Pediatr Res 2008, 64:131-134.
5. Lee L.J., Lupo P.J. Maternal smoking during pregnancy and the risk of congenital heart defects in offspring: a systematic review and metaanalysis. Pediatr Cardiol 2013, 34:398-407.
6. Geelhoed J.J., El Marroun H., Verburg B.O., van Osch-Gevers L., Hofman A., Huizink A.C., et al. Maternal smoking during pregnancy, fetal arterial resistance adaptations and cardiovascular function in childhood. BJOG 2011, 118:755-762.
7. Raitakari O.T., Juonala M., Kähönen M., Taittonen L., Laitinen T., Mäki-Torkko N., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 2003, 290:2277-2283.
8. Knoflach M., Kiechl S., Kind M., Said M., Sief R., Gisinger M., et al. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation 2003, 108:1064-1069.
9. Luck W., Nau H., Hansen R., Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther 1985, 8:384-395.
10. Swauger J.E., Steichen T.J., Murphy P.A., Kinsler S. An analysis of the mainstream smoke chemistry of samples of the U. S. cigarette market acquired between 1995 and 2000. Regul Toxicol Pharmacol 2002, 35:142-156.
11. Ma N., Nicholson C.J., Wong M., Holloway A.C., Hardy D.B. Fetal and neonatal exposure to nicotine leads to augmented hepatic and circulating triglycerides in adult male offspring due to increased expression of fatty acid synthase. Toxicol Appl Pharmacol 2014, 275:1-11.
12. Luck W., Nau H. Nicotine and cotinine concentrations in serum and urine of infants exposed via passive smoking or milk from smoking mothers. J Pediatr 1985, 107:816-820.
13. Dahlstrom A., Lundell B., Curvall M., Thapper L. Nicotine and cotinine concentrations in the nursing mother and her infant. Acta Paediatr Scand 1990, 79:142-147.
14. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev 2005, 19:2783-2810.
15. Javelaud D., Mauviel A. Mammalian transforming growth factor-betas: Smad signaling and physiopathological roles. Int J Biochem Cell Biol 2004, 36:1161-1165.
16. Annes J.P., Munger J.S., Rifkin D.B. Making sense of latent TGFbeta activation. J Cell Sci 2003, 116:217-224.
17. Millan F.A., Denhez F., Kondaiah P., Akhurst R.J. Embryonic gene expression patterns of TGF-beta 1, beta 2, and beta 3 suggest different developmental function in vivo. Development 1991, 111:131-143.
18. Mercado-Pimentel M.E., Runyan R.B. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 2007, 185:146-156.
19. Edgley A.J., Krum H., Kelly D.J. Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β. Cardiovasc Ther 2012, 30:e30-e40.
20. Khan R., Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006, 118:10-24.
21. Morais C., Small D.M., Vesey D.A., Martin J., Johnson D.W., Gobe G.C. Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy. Biochem Biophys Res Commun 2014, 444:332-337.
22. Cucina A., Sapienza P., Corvino V., Borrelli V., Mariani V., Randone B., et al. Nicotine-induced smooth muscle cell proliferation is mediated through bFGF and TGF-beta 1. Surgery 2000, 127:316-322.
23. Rodella L.F., Rossini C., Favero G., Foglio E., Loreto C., Rezzani R. Nicotine-induced morphological changes in rat aorta: the protective role of melatonin. Cells Tissues Organs 2012, 195:252-259.
24. Shan H., Zhang Y., Lu Y., Zhang Y., Pan Z., Cai B., et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009, 83:465-472.
25. Tong W1, Xue Q., Li Y., Zhang L. Maternal hypoxia alters matrix metalloproteinase expression patterns and causes cardiac remodeling in fetal and neonatal rats. Am J Physiol Heart Circ Physiol 2011, 301:H2113-H2121.
26. Corstius H.B., Zimanyi M.A., Maka N., Herath T., Thomas W., van der Laarse A., et al. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res 2005, 57:796-800.
27. Minicucci M.F., Azevedo P.S., Paiva S.A., Zornoff L.A. Cardiovascular remodeling induced by passive smoking. Inflamm Allergy Drugs Targets 2009, 8:334-339.
28. Talukder M.A., Johnson W.M., Varadharaj S., Lian J., Kearns P.N., El-Mahdy M.A., et al. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol 2011, 300:H388-H396.
29. Murrin L.C., Ferrer J.R., Wanyun Z., Haley N.J. Nicotine administration to rats: methodological considerations. Life Sci 1987, 40:1699-1708.
30. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., Widmer H.R. Prenatal adverse effects of nicotine on the developing brain. Prog Brain Res 1988, 73:137-157.
31. Boychuk C.R1, Hayward L.F. Prenatal nicotine exposure alters postnatal cardiorespiratory integration in young male but not female rats. Exp Neurol 2011, 232:212-221.
32. Scherrer-Crosbie M., Ullrich R., Bloch K.D., Nakajima H., Nasseri B., Aretz H.T., et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 2001, 104:1286-1291.
33. Zhong Y.S., Yu C.H., Ying H.Z., Wang Z.Y., Cai H.F. Prophylactic effects of Orthosiphon stamineus Benth. extracts on experimental induction of calcium oxalate nephrolithiasis in rats. J Ethnopharmacol 2012, 144:761-767.
34. Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 2007, 190:269-319.
35. Zhou X., Sheng Y., Yang R., Kong X. Nicotine promotes cardiomyocyte apoptosis via oxidative stress and altered apoptosis-related gene expression. Cardiology 2010, 115:243-250.
36. Gumustekin K., Taysi S., Alp H.H., Aktas O., Oztasan N., Akcay F., et al. Vitamin E and Hippophea rhamnoides L. extract reduce nicotine-induced oxidative stress in rat heart. Cell Biochem Funct 2010, 28:329-333.
37. Demiralay R., Gürsan N., Erdem H. The effects of erdosteine, N-acetylcysteine and vitamin E on nicotine-induced apoptosis of cardiac cells. J Appl Toxicol 2007, 27:247-254.
38. Das A., Dey N., Ghosh A., Das S., Chattopadhyay D.J., Chatterjee I.B. Molecular and cellular mechanisms of cigarette smoke-induced myocardial injury: prevention by vitamin C. PLoS One 2012, 7:e44151.
39. Rosenkranz S., Flesch M., Amann K., Haeuseler C., Kilter H., Seeland U., et al. Alterations of b-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1. Am J Physiol Heart Circ Physiol 2002, 283:H1253-H1262.
40. Waspe L.E., Ordahl C.P., Simpson P.C. The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor stimulated hypertrophy of cultured rat heart myocytes. J Clin Investig 1990, 85:1206-1214.
41. Chemaly E.R., Hadri L., Zhang S., Kim M., Kohlbrenner E., Sheng J., et al. Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats. J Mol Cell Cardiol 2011, 51:144-155.
42. Lim J.Y., Park S.J., Hwang H.Y., Park E.J., Nam J.H., Kim J., et al. TGF-β1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J Mol Cell Cardiol 2005, 39:627-636.
43. Eghbali M., Weber K.T. Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem 1990, 96:1-14.
44. McCurdy S., Baicu C.F., Heymans S., Bradshaw A.D. Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC). J Mol Cell Cardiol 2010, 48:544-549.
45. Katoh M. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review). Int J Mol Med 2013, 32:763-767.